作 者: ();
机构地区: 江门市中心医院
出 处: 《中国继续医学教育》 2020年第15期163-165,共3页
摘 要: 目的研究参麦注射液与注射用丹参多酚酸盐辅助治疗冠心病心力衰竭的成本与效果。方法选取2017年4月-2018年4月医院收治的冠心病心力衰竭患者80例,随机分为A组和B组,每组40例。A组使用参麦注射液治疗,B组使用注射用丹参多酚酸盐治疗。比较两组的治疗效果,治疗后的心功能指标,以及治疗治疗药物成本。结果A组治疗总有效率为95.00%,高于B组的75.00%(P<0.05)。A组治疗后LVEE(49.73±4.63)%、6MWT(313.65±13.02)m,分别高于B组的(39.50±4.50)%、(286.50±14.05)m;A组治疗后LVEDd(42.18±2.73)mm、LVESd(40.56±4.17)mm,分别低于B组的(53.75±4.32)mm、(50.62±4.72)mm(P<0.05)。A组治疗药物成本(1153.43±113.14)元,低于B组的(2965.66±134.62)元(P<0.05)。结论在冠心病心力衰竭的辅助治疗中,使用参麦注射液能够进一步提高疗效,改善患者心功能指标,同时药物成本更低,效果更为理想。 Objective To study the cost and effect of shenmai injection and salvia miltiorrhiza polyphenolates(salvia miltiorrhiza polyphenolates)in the treatment of coronary heart failure.Methods 80 patients with coronary heart failure admitted to the hospital from April 2017 to April 2018 were randomly divided into group A and group B,with 40 patients in each group.Group A was treated with shenmai injection,and group B was treated with salvia miltiorrhiza polyphenolates for injection.The two groups were compared in terms of treatment effect,cardiac function after treatment,and the cost of therapeutic drugs.Results The total effective rate was 95.00%in group A,which was higher than 75.00%in group B,with significant difference(P<0.05).After treatment,LVEE(49.73±4.63)%and 6MWT(313.65±13.02)m were higher in group A than in group B(39.50±4.50)%and 286.50±14.05)m,respectively.After treatment,LVEDd(42.18±2.73)mm and LVESd(40.56±4.17)mm in group A were lower than those in group B(53.75±4.32)mm and 50.62±4.72)mm,respectively,with significant differences(P<0.05).The cost of drugs in group A was(1153.43±113.14)yuan,which was lower than that in group B(2965.66±134.62)yuan,showing A significant difference(P<0.05).Conclusion In the adjuvant treatment of coronary heart failure,the use of shenmai injection can further improve the curative effect,improve the cardiac function index of patients,at the same time,the drug cost is lower,the effect is more ideal.